243 related articles for article (PubMed ID: 15618153)
1. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.
Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
Infect Immun; 2005 Jan; 73(1):181-92. PubMed ID: 15618153
[TBL] [Abstract][Full Text] [Related]
2. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
3. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
[TBL] [Abstract][Full Text] [Related]
4. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.
Duthie MS; Kahn SJ
Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307
[TBL] [Abstract][Full Text] [Related]
5. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
6. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
7. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.
Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
Infect Immun; 2005 Mar; 73(3):1890-4. PubMed ID: 15731095
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
Martins GA; Tadokoro CE; Silva RB; Silva JS; Rizzo LV
J Immunol; 2004 Apr; 172(8):4893-901. PubMed ID: 15067068
[TBL] [Abstract][Full Text] [Related]
9. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.
Miyahira Y; Katae M; Takeda K; Yagita H; Okumura K; Kobayashi S; Takeuchi T; Kamiyama T; Fukuchi Y; Aoki T
Infect Immun; 2003 Mar; 71(3):1234-41. PubMed ID: 12595437
[TBL] [Abstract][Full Text] [Related]
10. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
11. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
Sprengers D; Sillé FC; Derkow K; Besra GS; Janssen HL; Schott E; Boes M
Gastroenterology; 2008 Jun; 134(7):2132-43. PubMed ID: 18549881
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
13. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
14. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
15. Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.
Une C; Andersson J; Orn A
Clin Exp Immunol; 2003 Nov; 134(2):195-201. PubMed ID: 14616777
[TBL] [Abstract][Full Text] [Related]
16. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi.
Une C; Andersson J; Eloranta ML; Sunnemark D; Harris RA; Orn A
Clin Exp Immunol; 2000 Sep; 121(3):499-505. PubMed ID: 10971517
[TBL] [Abstract][Full Text] [Related]
18. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
19. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
20. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
